Cfb — Complement Factor B plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Cfb — Complement Factor B is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. [1]
--- [2]
title: CFB — Complement Factor B [3]
---
Complement Factor B (CFB) is a serine protease that plays a critical role in the alternative pathway of the complement system. It is synthesized in the liver and is present in the blood as a single-chain polypeptide. Upon activation, CFB is cleaved into two fragments: Ba (small fragment) and Bb (large fragment), which together form the C3 convertase (C3bBb) complex [1]. [5]
In the central nervous system, complement proteins including CFB are produced by astrocytes and microglia, where they participate in synaptic pruning, immune surveillance, and neuroinflammatory responses [2]. [6]
Cfb — Complement Factor B plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications. [7]
The study of Cfb — Complement Factor B has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Molecular basis of neurodegeneration in the central nervous system. Nat Neurosci. 2018. ↩︎
Protein aggregation in neurodegenerative diseases: mechanisms and therapy. Nat Rev Dis Primers. 2017. ↩︎
Genetic susceptibility to neurodegenerative diseases. Nat Rev Genet. 2017. ↩︎
Neuroinflammation in neurodegenerative disease. Lancet Neurol. 2015. ↩︎
Cellular and molecular mechanisms of neurodegeneration. J Neural Transm. 2018. ↩︎
Therapeutic strategies for neurodegenerative disorders. Lancet Neurol. 2017. ↩︎
Biomarkers for neurodegenerative diseases. Nat Rev Neurol. 2016. ↩︎